Effective treatment of moderate and severity psoriasis vulgaris by acitretine

  • Lê Đức Vân Bệnh viện Da liễu Thanh Hóa
  • Đặng Văn Em Bệnh viện Trung ương Quân đội 108
  • Đặng Thị Dịu Hiền Bệnh viện Trung ương Quân đội 108

Main Article Content

Keywords

acitretine, Psoriasis vugaris

Abstract

Objective: To evaluate the results of treatment of moderate and severe psoriasis vulgaris by oral acitretine. Subject and method: 40 patients with moderate and severe psoriasis vulgaris, 30 men, 10 women, mean age 59.23 ± 13.39 and PASI: 18.53 ± 3.83, moderate level 26 patients, severe severity 14 patients were treated inpatient at Thanh Hoa Dermatology Hospital from 3-2022 to 8-2022. Dosage of acitretine was 25mg/day × 8 weeks. Evaluation of clinical treatment results, side effects before and after treatment. Result: PASI decreased 78.58% (18.53 ± 3.83 decreased to 3.97 ± 0.92). In which, good 82.5%, quite 17.5%. Side effects: Dry lips 87.5%, dry eyes 30%, dry skin 20% and triglycerides, HDL-C, LDL-C increased statistically, all with p<0.001. Conclusion: Acitretine is effective in treating moderate and severe of psoriasis vugaris.

Article Details

References

1. Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K (2012) Fitzpatrick's dermatology in general medicine, 8e. McGrawHill Medical: 2421-2429.
2. Đặng Văn Em (2013) Bệnh vảy nến-Sinh bệnh học và chiến lược điều trị. Nhà xuất bản Y học, tr. 246.
3. Lynde CW, Poulin Y, Vender R, Bourcier M, Khalil S (2014) Interleukin 17A: Toward a new understanding of psoriasis pathogenesis. Journal of the American Academy of Dermatology 71(1): 141-150.
4. Redon A, Knut Scha'kel (2019) Psoriasis pathogenesis and treatment. Int. J. Mol. Sci 20(6): 1475.
5. Đỗ Tiến Bộ (2012) Nghiên cứu đặc điểm lâm sàng, yếu tố liên quan và hiệu quả điều trị bệnh vảy nến thông thường bằng uống vitamin A acid (Soriatane). Luận văn bác sĩ chuyên khoa 2, Đại học Y Hà Nội.
6. Ormerod A, Campalani E, Goodfield M (2010) British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. British Journal of Dermatology 162(5): 952-963.
7. Pai VV, Phadke D, Shukla P, Naik K (2019) Fixed tapering dosage of acitretin in patients with psoriasis: A short-term analysis of clinical efficacy and its effects on biochemical parameters. Indian journal of dermatology 64(3): 213.
8. Kragballe K, Jansen C, Geiger J et al (1989) A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study. Acta dermato-venereologica 69(1): 35-40.
9. Kircik L, Yaroshinksy A (2007) Efficacy and safety of low-dose acitretin for the treatment of moderate-to-severe plaque-type psoriasis. Paper presented at: Journal of investigative Dermatology 2007.